The neurotoxicity of cancer chemotherapy

Neurologist

Volumn 4, Issue 2, 1998, Pages 43-53

  Gilbert, Mark R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Neuroprotective agents; Neurotoxicity

Indexed keywords

ALPHA INTERFERON; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; BUSULFAN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; FLUOROURACIL; IFOSFAMIDE; INTERLEUKIN 2; METHOTREXATE; METRONIDAZOLE; MISONIDAZOLE; NITROSOUREA DERIVATIVE; PACLITAXEL; PROCARBAZINE; VINCA ALKALOID;

ARTICLE; BRAIN DISEASE; CANCER; CANCER CHEMOTHERAPY; CRANIAL NERVE PARALYSIS; DEMENTIA; DRUG INDUCED DISEASE; HUMAN; INTRASPINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; OTOTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SEIZURE; SPINAL CORD COMPRESSION;

EID: 0031894782     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-199803000-00001     Document Type: Article

References (4)

1. Rowinsky EK, Gilbert MR, McGuire \VP, Noe DA, Grochow LB, Forastiere AA, et al. Sequences of taxol and cisplatin: a phase I and pharmacologie study. J Clin Oncol 1991;9:1692-703.
2. Chaudry V, Rowinsky EK, Sartorius SE, Donehower RC, Comblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies. Ann Neurol 1994:35:304-11.
3. Price RA, Jamieson PA. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 1975;35:306-18.
4. Hara T, Kishikawa T, Miyazaki S, Ishii E, Goya N. Central nervous system complications in childhood leukemia. Am J Pediatr Hematol Oncol 1984;6:129-36.